{
      "brief_title": [
            "safety",
            "efficacy",
            "atrasentan",
            "men",
            "hormone",
            "naive",
            "prostate",
            "cancer",
            "exhibit",
            "early",
            "sign",
            "biochemical",
            "failure"
      ],
      "brief_summary": [
            "purpose",
            "phase",
            "ii",
            "randomize",
            "placebo",
            "control",
            "study",
            "evaluate",
            "safety",
            "efficacy",
            "10",
            "mg",
            "atrasentan",
            "hormone",
            "naive",
            "subject",
            "measure",
            "rate",
            "rise",
            "psa",
            "primary",
            "objective"
      ],
      "condition": [
            "prostatic",
            "neoplasm"
      ],
      "intervention_type": [
            "drug"
      ],
      "intervention_name": [
            "atrasentan"
      ],
      "criteria": [
            "inclusion",
            "criterion",
            "prostate",
            "adenocarcinoma",
            "radical",
            "prostatectomy",
            "psa",
            "5",
            "psadt",
            "1",
            "year",
            "exclusion",
            "criterion",
            "previous",
            "hormonal",
            "therapy",
            "salvage",
            "therapy",
            "pelvis",
            "within",
            "3",
            "month",
            "prior",
            "randomization"
      ],
      "gender": [
            "male"
      ],
      "minimum_age": [
            "19",
            "year"
      ],
      "maximum_age": [],
      "healthy_volunteers": false,
      "id": "NCT00038662.xml"
}